Cargando…

Tideglusib, a prospective alternative to nonoxynol-9 contraceptive

OBJECTIVES: We aimed to evaluate the antifertility activity and vaginal irritation effects of tideglusib in vivo using rabbit models and to evaluate the cytotoxical effects of tideglusib to sperm, vaginal cells and vaginal bacteria (L. acidophilus) in vitro. STUDY DESIGN: We treated female rabbits w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhiting, Shu, Niyan, Wang, Yuzhu, Yang, Yiting, Shao, Zhiyu, Tian, Fang, Xia, Minjie, Wang, Zhikai, Wang, Xin, Feng, Xing, Huang, Xianliang, Li, Weihua, Yu, Heguo, Diao, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286178/
https://www.ncbi.nlm.nih.gov/pubmed/32550526
http://dx.doi.org/10.1016/j.conx.2019.100007
_version_ 1783544829354967040
author Chen, Zhiting
Shu, Niyan
Wang, Yuzhu
Yang, Yiting
Shao, Zhiyu
Tian, Fang
Xia, Minjie
Wang, Zhikai
Wang, Xin
Feng, Xing
Huang, Xianliang
Li, Weihua
Yu, Heguo
Diao, Hua
author_facet Chen, Zhiting
Shu, Niyan
Wang, Yuzhu
Yang, Yiting
Shao, Zhiyu
Tian, Fang
Xia, Minjie
Wang, Zhikai
Wang, Xin
Feng, Xing
Huang, Xianliang
Li, Weihua
Yu, Heguo
Diao, Hua
author_sort Chen, Zhiting
collection PubMed
description OBJECTIVES: We aimed to evaluate the antifertility activity and vaginal irritation effects of tideglusib in vivo using rabbit models and to evaluate the cytotoxical effects of tideglusib to sperm, vaginal cells and vaginal bacteria (L. acidophilus) in vitro. STUDY DESIGN: We treated female rabbits with vaginal tideglusib 1 mM, nonoxynol-9 (N-9) or vehicle control (Poloxamer 407). In experiment 1, we sacrificed females (n = 6 each) after 10 days of daily administration and assessed vaginal histological changes using Eckstein irritation score. In experiment 2, females (n = 9 each) received estradiol benzoate to induce ovulation 24 h prior to vaginal treatment followed by introduction of a fertile male. These females underwent necropsy at the 21st day to assess pregnancy status. In experiment 3, we used an HTM-TOX IVOS sperm motility analyzer and scanning electron microscopy (SEM) to evaluate the effect of tideglusib on human sperm samples. In experiment 4, we evaluated the effect of tideglusib on lactobacillus and vaginal cell growth in vitro. RESULTS: The total irritation score of tideglusib vs. N-9 was 3.4 ± 2.07 vs. 7.8 ± 3.82, p <.05. The pregnancy rate of tideglusib, N-9 and control group was 11.1%, 0% and 88.9%, respectively. Tideglusib exhibited a dose-dependent spermostatic/spermicidal activity, and the minimum effective concentrations of tideglusib and N-9 were 8.724 ± 3.047 μM and 219.75 ± 41.78 μM, respectively. SEM and transmission electron microscopy revealed acrosomal membrane impairments caused by tideglusib. Tideglusib was much less toxic to vaginal cells and L. acidophilus than N-9 in vitro. CONCLUSIONS: Evaluation using rabbit models indicated that tideglusib is a prospective spermicidal contraceptive with low vaginal irritation effects. IMPLICATIONS: Tideglusib or tideglusib analogues may be a contraceptive with perspective to replace N-9. It is possible for a spermicide to balance spermicidal activity and vaginal/cervical irritation effects very well.
format Online
Article
Text
id pubmed-7286178
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72861782020-06-16 Tideglusib, a prospective alternative to nonoxynol-9 contraceptive Chen, Zhiting Shu, Niyan Wang, Yuzhu Yang, Yiting Shao, Zhiyu Tian, Fang Xia, Minjie Wang, Zhikai Wang, Xin Feng, Xing Huang, Xianliang Li, Weihua Yu, Heguo Diao, Hua Contracept X Article OBJECTIVES: We aimed to evaluate the antifertility activity and vaginal irritation effects of tideglusib in vivo using rabbit models and to evaluate the cytotoxical effects of tideglusib to sperm, vaginal cells and vaginal bacteria (L. acidophilus) in vitro. STUDY DESIGN: We treated female rabbits with vaginal tideglusib 1 mM, nonoxynol-9 (N-9) or vehicle control (Poloxamer 407). In experiment 1, we sacrificed females (n = 6 each) after 10 days of daily administration and assessed vaginal histological changes using Eckstein irritation score. In experiment 2, females (n = 9 each) received estradiol benzoate to induce ovulation 24 h prior to vaginal treatment followed by introduction of a fertile male. These females underwent necropsy at the 21st day to assess pregnancy status. In experiment 3, we used an HTM-TOX IVOS sperm motility analyzer and scanning electron microscopy (SEM) to evaluate the effect of tideglusib on human sperm samples. In experiment 4, we evaluated the effect of tideglusib on lactobacillus and vaginal cell growth in vitro. RESULTS: The total irritation score of tideglusib vs. N-9 was 3.4 ± 2.07 vs. 7.8 ± 3.82, p <.05. The pregnancy rate of tideglusib, N-9 and control group was 11.1%, 0% and 88.9%, respectively. Tideglusib exhibited a dose-dependent spermostatic/spermicidal activity, and the minimum effective concentrations of tideglusib and N-9 were 8.724 ± 3.047 μM and 219.75 ± 41.78 μM, respectively. SEM and transmission electron microscopy revealed acrosomal membrane impairments caused by tideglusib. Tideglusib was much less toxic to vaginal cells and L. acidophilus than N-9 in vitro. CONCLUSIONS: Evaluation using rabbit models indicated that tideglusib is a prospective spermicidal contraceptive with low vaginal irritation effects. IMPLICATIONS: Tideglusib or tideglusib analogues may be a contraceptive with perspective to replace N-9. It is possible for a spermicide to balance spermicidal activity and vaginal/cervical irritation effects very well. Elsevier 2019-04-25 /pmc/articles/PMC7286178/ /pubmed/32550526 http://dx.doi.org/10.1016/j.conx.2019.100007 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Chen, Zhiting
Shu, Niyan
Wang, Yuzhu
Yang, Yiting
Shao, Zhiyu
Tian, Fang
Xia, Minjie
Wang, Zhikai
Wang, Xin
Feng, Xing
Huang, Xianliang
Li, Weihua
Yu, Heguo
Diao, Hua
Tideglusib, a prospective alternative to nonoxynol-9 contraceptive
title Tideglusib, a prospective alternative to nonoxynol-9 contraceptive
title_full Tideglusib, a prospective alternative to nonoxynol-9 contraceptive
title_fullStr Tideglusib, a prospective alternative to nonoxynol-9 contraceptive
title_full_unstemmed Tideglusib, a prospective alternative to nonoxynol-9 contraceptive
title_short Tideglusib, a prospective alternative to nonoxynol-9 contraceptive
title_sort tideglusib, a prospective alternative to nonoxynol-9 contraceptive
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286178/
https://www.ncbi.nlm.nih.gov/pubmed/32550526
http://dx.doi.org/10.1016/j.conx.2019.100007
work_keys_str_mv AT chenzhiting tideglusibaprospectivealternativetononoxynol9contraceptive
AT shuniyan tideglusibaprospectivealternativetononoxynol9contraceptive
AT wangyuzhu tideglusibaprospectivealternativetononoxynol9contraceptive
AT yangyiting tideglusibaprospectivealternativetononoxynol9contraceptive
AT shaozhiyu tideglusibaprospectivealternativetononoxynol9contraceptive
AT tianfang tideglusibaprospectivealternativetononoxynol9contraceptive
AT xiaminjie tideglusibaprospectivealternativetononoxynol9contraceptive
AT wangzhikai tideglusibaprospectivealternativetononoxynol9contraceptive
AT wangxin tideglusibaprospectivealternativetononoxynol9contraceptive
AT fengxing tideglusibaprospectivealternativetononoxynol9contraceptive
AT huangxianliang tideglusibaprospectivealternativetononoxynol9contraceptive
AT liweihua tideglusibaprospectivealternativetononoxynol9contraceptive
AT yuheguo tideglusibaprospectivealternativetononoxynol9contraceptive
AT diaohua tideglusibaprospectivealternativetononoxynol9contraceptive